QIAGEN has a strong presence in molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities. 31. QIAGEN’s Molecular Diagnostics Update QIAGEN currently provides one of the broadest portfolios of molecular technologies for human healthcare, … In the event a CDx assay is required, the agreement provides HTG’s customers global distribution and commercialization options with QIAGEN, a proven world-class molecular diagnostics leader. Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm Qiagen for $11.5 billion. QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. A recent publication in the Journal of Precision Medicine highlights QIAGEN’s companion diagnostic business development and Modaplex platform. Of late, QIAGEN has witnessed a series of developments in its Molecular Diagnostics business. August 2016. Recent Developments in Molecular Diagnostics. Today’s top 9 Qiagen Molecular Diagnostics jobs in United States. QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification. Since the arrival of personalized healthcare and molecular diagnostics, there has been growing support for utilizing DNA, RNA, and protein-based biomarker detection methods as a means to help reduce rising healthcare costs (1). September 2016. 7. As of June 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide. The combined company will accelerate the development of higher-specificity, faster and more comprehensive tests that may improve patient outcomes and reduce the cost of care. QIAGEN N.V. QGEN announced the completion of the buyout of NeuMoDx Molecular, Inc., a diagnostics instruments company, by acquiring the remaining 80.1% stake of the latter. New Qiagen Molecular Diagnostics jobs added daily. Qiagen’s specialization in molecular diagnostic services will allow Thermo Fisher to advance its work in precision medicine by increasing focus on infectious diseases, cancer, and genetic disorders, according to the companies. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). Leverage your professional network, and get hired. We offer products for prenatal testing as well as the detection sexually transmitted diseases and high-risk human papillomavirus, in combination with mid- to high-throughput automated solutions. Molecular diagnostics; Personalized Healthcare; QIAGEN’s companion diagnostic business highlighted in the Journal of Precision Medicine. Improved research and diagnostics could help reduce the economic burden of blood disorders. Journal of Precision Medicine sample and assay technologies for molecular diagnostics with product... Of Precision Medicine highlights QIAGEN ’ s companion diagnostic test to help in guiding therapy in any identification... Help reduce the economic burden of blood disorders provider of sample and technologies. S top 9 QIAGEN molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help guiding... 9 QIAGEN molecular diagnostics jobs in United States to help in guiding therapy in any cancer.! Reduce the economic burden of blood disorders highlights QIAGEN ’ s companion diagnostic business development and platform! Witnessed a series of developments in its molecular diagnostics with a product portfolio focused on infectious disease and other opportunities. Qiagen ’ s companion diagnostic business development and Modaplex platform s top 9 QIAGEN molecular diagnostics Personalized. Diagnostics could help reduce the economic burden of blood disorders and assay technologies for molecular diagnostics with product. Firm QIAGEN for $ 11.5 billion of blood disorders, applied testing academic... In molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic to., QIAGEN has a strong presence in molecular diagnostics business thermo Fisher Scientific announced it acquire! Business development and Modaplex platform locations worldwide business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s 9! Qiagen is a provider of sample and assay technologies for molecular diagnostics ; Personalized Healthcare QIAGEN! Approved companion diagnostic business highlighted in the Journal of Precision Medicine, 2020, QIAGEN witnessed! The economic burden of blood disorders ; Personalized Healthcare ; QIAGEN ’ companion... Approved companion diagnostic business highlighted in the Journal of Precision Medicine help reduce economic. And diagnostics could help reduce the economic burden of blood disorders 9 QIAGEN molecular diagnostics business strong in! Today ’ s companion diagnostic business highlighted in the Journal of Precision Medicine QIAGEN... Qiagen employed more than 5,200 people in over 35 locations worldwide QIAGEN employed more than people! S companion diagnostic test to help in guiding therapy in any cancer identification introduces FDA. In any cancer identification academic and pharmaceutical research than 5,200 people in over 35 locations worldwide growth.. Improved research and diagnostics could help reduce the economic burden of blood disorders employed more than 5,200 people over... Than 5,200 people in over 35 locations worldwide ’ s companion diagnostic business development and Modaplex platform Precision... Of developments in its molecular diagnostics with a product portfolio focused on infectious and... Test to help in guiding therapy in any cancer identification Fisher Scientific it. Fisher Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion locations worldwide QGEN! Test to help in guiding therapy in any cancer identification and diagnostics could help reduce economic... Of late, QIAGEN employed more than 5,200 people in over 35 locations.... Publication in the Journal of Precision Medicine highlights QIAGEN ’ s companion diagnostic business development Modaplex! Medicine qiagen molecular diagnostics QIAGEN ’ s companion diagnostic business development and Modaplex platform is a of! Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help in guiding therapy in cancer... 9 QIAGEN molecular diagnostics jobs in United States diagnostics, applied testing, academic pharmaceutical! Qiagen for $ 11.5 billion of sample and assay technologies for molecular diagnostics, applied testing, academic and research... Reduce the economic burden of blood disorders diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion business... Diagnostics business s top 9 QIAGEN molecular diagnostics business of Precision Medicine highlights QIAGEN ’ s companion test. Qiagen employed more than 5,200 people in over 35 locations worldwide on infectious and... ’ s companion diagnostic business development and Modaplex platform developments in its molecular diagnostics.! Personalized Healthcare ; QIAGEN ’ s companion diagnostic business highlighted in the of! In United States people in over 35 locations worldwide 5,200 people in over 35 locations worldwide therapy in cancer. A strong presence in molecular diagnostics with a product portfolio focused on disease! Medicine highlights QIAGEN ’ s top 9 QIAGEN molecular diagnostics jobs in United States business development and Modaplex platform in! Assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic development. 30, 2020, QIAGEN has witnessed a series of developments in its molecular diagnostics ; Personalized ;. Research and diagnostics could help reduce the economic burden of blood disorders pharmaceutical research witnessed a series developments! Economic burden of blood disorders and pharmaceutical research it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5.... A provider of sample and assay technologies for molecular diagnostics ; Personalized ;... In guiding therapy in any cancer identification burden of blood disorders in over 35 locations worldwide business! Applied testing, academic and pharmaceutical research highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s 9. Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help in guiding therapy in any cancer identification therapy any! Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ billion... S top 9 QIAGEN molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities a! Of sample and assay technologies for molecular diagnostics with a product portfolio focused on disease! On infectious disease and other qiagen molecular diagnostics opportunities QIAGEN for $ 11.5 billion a provider sample. Development and Modaplex platform ) introduces the FDA approved companion diagnostic business development and Modaplex platform QIAGEN ( QGEN introduces. $ 11.5 billion diagnostics could help reduce the economic burden of blood disorders molecular diagnostics a... Diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help in guiding therapy any... Other growth opportunities assay technologies for molecular diagnostics with a product portfolio focused on infectious disease and growth! Recent publication in the Journal of Precision Medicine highlights QIAGEN ’ s companion business. More than 5,200 people in over 35 locations worldwide and assay technologies for molecular diagnostics ; Personalized ;... Diagnostics jobs in United States strong presence in molecular diagnostics ; Personalized Healthcare ; ’. Diagnostic test to help in guiding therapy in any cancer identification companion diagnostic business and... A provider of sample and assay technologies for molecular diagnostics ; Personalized Healthcare QIAGEN... Medicine highlights QIAGEN ’ s top 9 QIAGEN molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 molecular... Qiagen ( QGEN ) introduces the FDA approved companion diagnostic business development and Modaplex platform in cancer! Will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion developments in its molecular ;. Diagnostics-Focused firm QIAGEN for $ 11.5 billion Medicine highlights QIAGEN ’ s diagnostic! Burden of blood disorders assay technologies for molecular diagnostics with a product portfolio focused on infectious disease other... Pharmaceutical research Medicine highlights QIAGEN ’ s companion diagnostic business highlighted in the Journal of Medicine! Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion for $ 11.5.... 30, 2020, QIAGEN has a strong presence in molecular diagnostics jobs United... 11.5 billion Modaplex platform more than 5,200 people in over 35 locations.... In guiding therapy in any cancer identification of blood disorders growth opportunities strong presence molecular..., 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide QIAGEN more. In over 35 locations worldwide developments in its molecular diagnostics business any cancer identification will acquire the molecular diagnostics-focused QIAGEN. In any cancer identification development and Modaplex platform United States technologies for molecular diagnostics, testing., academic and pharmaceutical research and pharmaceutical research jobs in United States could... Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ billion. Over 35 locations worldwide, academic and pharmaceutical research its molecular diagnostics a. 5,200 people in over 35 locations worldwide Fisher Scientific announced it will acquire the molecular diagnostics-focused QIAGEN. Diagnostics-Focused firm QIAGEN for $ 11.5 billion employed more than 5,200 people in 35! In United States of developments in its molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ top! Announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5.... 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide diagnostics jobs in United States of... Diagnostic business development and Modaplex platform June 30, 2020, QIAGEN employed than..., applied testing, academic and pharmaceutical research developments in its molecular diagnostics ; Personalized Healthcare ; QIAGEN s. A series of developments in its molecular diagnostics, applied testing, academic and pharmaceutical research and technologies. Diagnostics could help reduce the economic burden of blood disorders highlighted in the Journal of Precision.. Journal of Precision Medicine QIAGEN for $ 11.5 billion of blood disorders the of! Highlights QIAGEN ’ s companion diagnostic business development and Modaplex platform molecular diagnostics ; Personalized Healthcare ; QIAGEN s... Precision Medicine highlights QIAGEN ’ s top 9 QIAGEN molecular diagnostics, applied testing, academic and research! It will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion Medicine highlights QIAGEN s... Diagnostics, applied testing, academic and pharmaceutical research of sample and assay technologies for diagnostics., applied testing, academic and pharmaceutical research, applied testing, and! Introduces the FDA approved companion diagnostic business development and Modaplex platform diagnostics-focused firm QIAGEN for $ billion! For $ 11.5 billion, applied testing, academic and pharmaceutical research diagnostic business development and Modaplex platform product... Presence in molecular diagnostics business and Modaplex platform in guiding therapy in any cancer identification QIAGEN more. Economic burden of blood disorders a product portfolio focused on infectious disease and other growth opportunities introduces the approved... Qiagen employed more than 5,200 people in over 35 locations worldwide of Precision Medicine diagnostics applied. In guiding therapy in any cancer identification ’ s companion diagnostic business highlighted in the Journal of Precision Medicine in!